er request than Pfizer and BioNTech filed for their shot this week.
Although there are indications that regulators could move swiftly on Pfizer's request, it is unclear how favourably they will view Moderna's more sweeping application. Outside scientists are sharply divided over whether another dose is necessary now, and if so, for whom. "It's also clear that protection is waning now pretty quickly a few months after your third dose," he said."So it's short-lived. The hope is that a second booster would restore it."
2022 3.18 = Thousand-s , of , *Blood-Sample*s , Test-ed , For , COVID-19 , Antibodies , Under , New-Surveillance- Program COVID-19 , Finger-Stick , Blood-Test = image
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »